Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Opioid Response topic

No spam. Unsubscribe anytime.

Committee advances bill requiring EDs to offer buprenorphine or methadone, sparking operational concerns

Public Health Committee · March 9, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Lawmakers advanced SB 365 to require emergency departments to initiate buprenorphine or methadone, provide bridge prescriptions or last‑dose letters, supply naloxone and refer patients to community providers. Members pressed hospital compensation, clinical‑judgment safeguards and the risk of EDs becoming ongoing treatment sites.

The Public Health committee voted to send SB 365, a proposal to establish a bridge program for emergency treatment and recovery navigation for people with opioid use disorder, to the floor after an extended debate over operations and funding.

Senator Ammoir, who described the measure as a way to “start the rehab” for people who arrive in emergency departments, said the bill would let clinicians provide buprenorphine or methadone when medically indicated, require a bridge prescription or a last‑dose letter for methadone, and mandate an offer of naloxone along with referral to community providers or treatment programs.

The bill’s sponsor defended the measure as lifesaving and emphasized clinical judgment: “This bill is not asking people to come to the emergency room. The people are coming to the emergency room,” Senator Ammoir said, adding that the measure preserves clinicians’ professional discretion when it is not medically indicated to initiate medication.

Opponents warned of unintended consequences. Representative Clara Ditria asked whether hospitals or insurers would cover the medication and who would ensure follow‑up care; she said she would vote no if the bill became an unfunded mandate on hospitals. “If it’s a referral and I’m given one of the two meds, who’s to stop me from not making an appointment and coming back to the hospital in a week?” she asked.

Senator Summers and Senator Gordon both said the legislation needs more precise operational language and safeguards to avoid creating an uncompensated burden on crowded emergency departments. Senator Gordon cited written recommendations from the Connecticut Hospital Association urging permissive, not mandatory, language and said he would vote no on the bill as drafted unless changes to protect clinicians’ judgment and address payment were adopted.

Supporters pointed to existing programs and clinical groups backing the approach. Senator Ammoir and other proponents said some Connecticut hospitals already initiate medication for opioid use disorder in the ED and that the bill aims to make access more consistent statewide.

After the discussion, the committee called the roll and the motion carried out of committee. The bill will be subject to further amendment and stakeholder negotiations on funding, liability language and implementation details.

What’s next: sponsors said they will consult with the Connecticut Hospital Association, emergency department clinicians and the opioid settlement advisory committee to refine language on clinical‑judgment protections and financing for medications and follow‑up referrals.